Form 4: Tectonic Therapeutic CEO Reports Stock Transaction
Insider Transaction (Form 4)
Alise Reicin, Chief Executive Officer and a Director of Tectonic Therapeutic, Inc., reported a transaction in 1,545 shares of common stock on September 25, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,545 Common Stock at $23.67 ($36,570) on September 25, 2026; holds 309,078 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alise Reicin — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Tax/exercise-price withholding | Common Stock | 1,545 | $24 | $36.6K | 309,078 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Tax/exercise-price withholding (1,545 shares) |
Keywords
insider transaction, Form 4, TECX, Tectonic Therapeutic, Inc., neutral, Alise Reicin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.